NCT04390854

Brief Summary

The aim of the present study is to assess clinically and radio-graphically the regenerative potential of immature permanent teeth with necrotic pulp using blood clot and Platelet rich fibrin scaffolds.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 6, 2018

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2020

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 8, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 18, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2020

Completed
Last Updated

November 4, 2020

Status Verified

November 1, 2020

Enrollment Period

1.5 years

First QC Date

May 8, 2020

Last Update Submit

November 2, 2020

Conditions

Keywords

Regenerative endodonticsOpen apexImmature necrotic teeth

Outcome Measures

Primary Outcomes (20)

  • Subjective pain assessment

    The patient will be asked about the presence of any pain or discomfort. Pain severity will be categorized as: no pain - mild pain - moderate pain - severe pain

    1 month

  • Subjective pain assessment

    The patient will be asked about the presence of any pain or discomfort. Pain severity will be categorized as: no pain - mild pain - moderate pain - severe pain

    3 months

  • Subjective pain assessment

    The patient will be asked about the presence of any pain or discomfort. Pain severity will be categorized as: no pain - mild pain - moderate pain - severe pain

    6 months

  • Subjective pain assessment

    The patient will be asked about the presence of any pain or discomfort. Pain severity will be categorized as: no pain - mild pain - moderate pain - severe pain

    12 months

  • Assessment of pulp vitality

    Pulp vitality will be assessed using thermal and electric pulp sensibility tests

    1 month

  • Assessment of pulp vitality

    Pulp vitality will be assessed using thermal and electric pulp sensibility tests

    3 months

  • Assessment of pulp vitality

    Pulp vitality will be assessed using thermal and electric pulp sensibility tests

    6 months

  • Assessment of pulp vitality

    Pulp vitality will be assessed using thermal and electric pulp sensibility tests

    12 months

  • Assessment of root development

    Continued root development will be assessed using cone beam computed tomography (CBCT) and compared with the contra-lateral healthy tooth

    1 month

  • Assessment of root development

    Continued root development will be assessed using cone beam computed tomography (CBCT) and compared with the contra-lateral healthy tooth

    3 months

  • Assessment of root development

    Continued root development will be assessed using cone beam computed tomography (CBCT) and compared with the contra-lateral healthy tooth

    6 months

  • Assessment of root development

    Continued root development will be assessed using cone beam computed tomography (CBCT) and compared with the contra-lateral healthy tooth

    12 months

  • Assessment of the size of periapical radiolucency

    Size of the lesion will be assessed using the periapical index score. The PAI provides an ordinal scale of 5 scores ranging from 1 (healthy) to 5 (severe periodontitis with exacerbating features).

    1 month

  • Assessment of the size of periapical radiolucency

    Size of the lesion will be assessed using Cone Beam Computed Tomography (CBCT).

    1 month

  • Assessment of the size of periapical radiolucency

    Size of the lesion will be assessed using the periapical index (PAI) score. The PAI provides an ordinal scale of 5 scores ranging from 1 (healthy) to 5 (severe periodontitis with exacerbating features).

    3 months

  • Assessment of the size of periapical radiolucency

    Size of the lesion will be assessed using Cone Beam Computed Tomography (CBCT).

    3 months

  • Assessment of the size of periapical radiolucency

    Size of the lesion will be assessed using the periapical index (PAI) score. The PAI provides an ordinal scale of 5 scores ranging from 1 (healthy) to 5 (severe periodontitis with exacerbating features).

    6 months

  • Assessment of the size of periapical radiolucency

    Size of the lesion will be assessed using Cone Beam Computed Tomography (CBCT).

    6 months

  • Assessment of the size of periapical radiolucency

    Size of the lesion will be assessed using the periapical index (PAI) score. The PAI provides an ordinal scale of 5 scores ranging from 1 (healthy) to 5 (severe periodontitis with exacerbating features).

    12 months

  • Assessment of the size of periapical radiolucency

    Size of the lesion will be assessed using Cone Beam Computed Tomography (CBCT).

    12 months

Study Arms (2)

Induced blood clot scaffold

ACTIVE COMPARATOR
Biological: Blood clot scaffold

Induced blood clot scaffold combined with Platelet rich fibrin

EXPERIMENTAL
Biological: Blood clot scaffold combined with PRF

Interventions

Bleeding will be induced in the canal by passing a size 30 sterile K-file 3 mm beyond the apex with the goal of having the entire canal filled with blood to the level of the cemento-enamel junction. Bleeding will be stopped just below the cemento enamel junction. Biodentine will be placed approximately 3-4 mm below the cementoenamel junction.

Induced blood clot scaffold

Platelet-rich fibrin will be prepared by drawing the patient blood into a 10mL test tube without the addition of an anticoagulant. To prevent the blood from coagulating after coming in contact with the glass tube, it will be centrifuged immediately using a table top centrifuge\*\* at 400 g force for 12 minutes. Then platelet-rich fibrin membrane will be placed into the canal space to a level 3 mm below the cemento-enamel junction using hand plugger following the induction of apical bleeding by passing a number 30 sterile hand file 3 mm beyond the apex of the tooth. Biodentine cap will be placed over the platelet-rich fibrin scaffold.

Induced blood clot scaffold combined with Platelet rich fibrin

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Necrotic incisors with immature roots
  • Pulp space not needed for post and core.
  • The patient has to be free from any coagulation disorders, with normal platelets count.
  • Good oral hygiene
  • Cooperative patient

You may not qualify if:

  • Internal or external root resorption.
  • Root fracture and/or alveolar fracture.
  • Previous root canal treatment.
  • Medically compromised patients
  • Uncooperative patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Alexandria University

Alexandria, 21512, Egypt

Location

Related Publications (9)

  • Bakhtiar H, Vatanpour M, Rayani A, Navi F, Asna-Ashari E, Ahmadi A, Jafarzadeh H. The plasma-rich in growth factor as a suitable matrix in regenerative endodontics: a case series. N Y State Dent J. 2014 Jun-Jul;80(4):49-53.

    PMID: 25219066BACKGROUND
  • Keswani D, Pandey RK. Revascularization of an immature tooth with a necrotic pulp using platelet-rich fibrin: a case report. Int Endod J. 2013 Nov;46(11):1096-104. doi: 10.1111/iej.12107. Epub 2013 Apr 13.

    PMID: 23581794BACKGROUND
  • Yassen GH, Eckert GJ, Platt JA. Effect of intracanal medicaments used in endodontic regeneration procedures on microhardness and chemical structure of dentin. Restor Dent Endod. 2015 May;40(2):104-12. doi: 10.5395/rde.2015.40.2.104. Epub 2014 Dec 24.

    PMID: 25984471BACKGROUND
  • Yassen GH, Sabrah AH, Eckert GJ, Platt JA. Effect of different endodontic regeneration protocols on wettability, roughness, and chemical composition of surface dentin. J Endod. 2015 Jun;41(6):956-60. doi: 10.1016/j.joen.2015.02.023. Epub 2015 Mar 29.

    PMID: 25823403BACKGROUND
  • Neha K, Kansal R, Garg P, Joshi R, Garg D, Grover HS. Management of immature teeth by dentin-pulp regeneration: a recent approach. Med Oral Patol Oral Cir Bucal. 2011 Nov 1;16(7):e997-1004. doi: 10.4317/medoral.17187.

    PMID: 21743418BACKGROUND
  • Lovelace TW, Henry MA, Hargreaves KM, Diogenes A. Evaluation of the delivery of mesenchymal stem cells into the root canal space of necrotic immature teeth after clinical regenerative endodontic procedure. J Endod. 2011 Feb;37(2):133-8. doi: 10.1016/j.joen.2010.10.009.

    PMID: 21238791BACKGROUND
  • Cotti E, Mereu M, Lusso D. Regenerative treatment of an immature, traumatized tooth with apical periodontitis: report of a case. J Endod. 2008 May;34(5):611-6. doi: 10.1016/j.joen.2008.02.029.

    PMID: 18436046BACKGROUND
  • Cehreli ZC, Isbitiren B, Sara S, Erbas G. Regenerative endodontic treatment (revascularization) of immature necrotic molars medicated with calcium hydroxide: a case series. J Endod. 2011 Sep;37(9):1327-30. doi: 10.1016/j.joen.2011.05.033. Epub 2011 Jul 13.

    PMID: 21846559BACKGROUND
  • Law AS. Considerations for regeneration procedures. J Endod. 2013 Mar;39(3 Suppl):S44-56. doi: 10.1016/j.joen.2012.11.019.

    PMID: 23439044BACKGROUND

MeSH Terms

Conditions

Dental Pulp Necrosis

Interventions

Prolactin-Releasing Hormone

Condition Hierarchy (Ancestors)

Dental Pulp DiseasesTooth DiseasesStomatognathic DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Hypothalamic HormonesPeptide HormonesHormonesHormones, Hormone Substitutes, and Hormone AntagonistsNeuropeptidesPeptidesAmino Acids, Peptides, and ProteinsNerve Tissue ProteinsProteins

Study Officials

  • Mahmoud MS Hassan, M.Sc

    Faculty of Dentistry, Alexandria University, Egypt

    PRINCIPAL INVESTIGATOR
  • Mohamed Ibrahim, PhD

    Faculty of Dentistry, Alexandria University, Egypt

    STUDY DIRECTOR
  • Sybel M Moussa, PhD

    Faculty of Dentistry, Alexandria University, Egypt

    STUDY DIRECTOR
  • Nihal A Lehita, PhD

    Faculty of Dentistry, Alexandria University, Egypt

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The radiographic specialist and the statistician will be blinded to treatment group
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Teaching Assistant of Dental Public Health and Statistician

Study Record Dates

First Submitted

May 8, 2020

First Posted

May 18, 2020

Study Start

July 6, 2018

Primary Completion

January 20, 2020

Study Completion

August 30, 2020

Last Updated

November 4, 2020

Record last verified: 2020-11

Locations